(Q38545195)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author

Alexandra Boer Kimball

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Joel M Gelfand

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Kenneth J Rothman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Gregory Kricorian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

David Pariser

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Paul S Yamauchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Alan Menter

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Craig F Teller

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Girish Aras

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Neil A Accortt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Michele Hooper

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Kara Creamer Rice

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

26 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

115-122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

Biologic therapy in psoriasis: perspectives on associated risks and patient management

20 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4758511

Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4758511

The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4758511

Psoriasis assessment tools in clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4758511

OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4758511

Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4758511

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4758511

Clinical trial safety and mortality analyses in patients receiving etanercept across approved indications.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4758511

Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4758511

The Risk of Lymphoma in Patients with Psoriasis

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25264239

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The risk of malignancy associated with psoriasis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25264239

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JAAD.2014.08.050

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

25264239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25264239%20AND%20SRC:MED&resulttype=core&format=json